Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.1.2 (
glutamate dehydrogenase
)
4,380
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Eel liver
glutamate dehydrogenase
(
GDH
) [EC 1.4.1.3] was eightfold activated by trypsin and the molecular weight of the subunit of the native
GDH
decreased from 54,000 to 50,000. The C-terminal amino acid of both subunits was Thr. One peptide was released after proteolysis of the native
GDH
by trypsin and purified by anhydrotrypsin agarose and reversed-phase HPLC. The isolated peptide consisted of 39 amino acids and its amino acid sequence was as follows: H2NS-E-A-V-E-K-E-D-D-P-N-F-F-K-M-V-E-G-F-F-D-K-G-A-A-I- V-E-N-K-L-V-E-E-D-L-K-T-R-COOH. The peptide contained the N-terminal of the native
GDH
and its molecular weight was calculated to be 4,413. We concluded that the trypsin-catalyzed activation was caused by release of this peptide from the native
GDH
.
p-Chloromercuribenzoic acid
inhibited the activity of the trypsin-treated
GDH
, but stimulated that of the native
GDH
. The response of trypsin-treated
GDH
to ADP and GTP was decreased compared with that of the native
GDH
.
...
PMID:The trypsin-catalyzed activation of glutamate dehydrogenase purified from eel liver. 163 63